Related Experiment Video
Updated: Feb 8, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting
Wei Wang1,2, Pang-Hu Zhou3, Wei Hu4
1Department of Urology, The First Affiliated Hospital of Anhui Medical University and Institute of Urology, Anhui Medical University, Hefei, Anhui, 232200, China.
Abstract:
Recent studies have reported that CTS can alleviate cardiac fibrosis. However, the effects of CTS on kidney fibrosis and EMT are still unknown. This study explored whether CTS could attenuate tubulointerstitial fibrosis as well as EMT, and investigated the potential underlying mechanisms. In this study, an in vivo UUO mouse model and an in vitro TGF-β1 stimulated normal renal tubular kidney epithelial cell model were established. In UUO model, administration of 50 mg kg-1 day-1 CTS markedly decreased the occurrence of kidney injury and the accumulation of fibronectin and collagen-1. In addition, CTS reduced the expression level of α-SMA but retained E-cadherin in obstructed kidneys. In vitro, CTS suppressed the expression of fibronectin, collagen-1 and α-SMA but retained that of E-cadherin. Furthermore, CTS selectively abolished the activation of Smad3 and suppressed the nuclear translocation of Smad2, Smad3 and Smad4. CTS could block the promoter activity of integrin β1 induced by Smad3. Furthermore, CTS inhibited Smad3 binding to integrin β1 promoter sequences. These data suggest that CTS can ameliorate kidney fibrosis and EMT, at least in part, by inhibiting the TGF-β1/Smad3/integrin β1 signaling pathway.
Insights
This study shows that Compound X (CTS) reduces kidney fibrosis and epithelial-to-mesenchymal transition (EMT) in mice and cell models. CTS works by inhibiting the TGF-β1/Smad3/integrin β1 pathway, offering a potential therapeutic strategy for kidney diseases.
Area of Science:
- Nephrology
- Cell Biology
- Pharmacology
Background:
- Cardiac fibrosis can be alleviated by Compound X (CTS).
- The effects of CTS on kidney fibrosis and epithelial-to-mesenchymal transition (EMT) remain largely unknown.
- Kidney fibrosis is a significant contributor to chronic kidney disease progression.
Purpose of the Study:
- To investigate the potential of CTS in attenuating tubulointerstitial fibrosis and EMT.
- To explore the underlying molecular mechanisms by which CTS exerts its effects.
- To determine if CTS impacts the TGF-β1/Smad3/integrin β1 signaling pathway.
Main Methods:
- Established an in vivo unilateral ureter obstruction (UUO) mouse model.
- Developed an in vitro TGF-β1 stimulated renal tubular epithelial cell model.
- Administered CTS (50 mg kg-1 day-1) to UUO mice and treated cell models.
Main Results:
- CTS significantly decreased kidney injury, fibronectin, and collagen-1 accumulation in UUO mice.
- CTS reduced alpha-smooth muscle actin (α-SMA) expression while preserving E-cadherin in obstructed kidneys.
- In vitro, CTS suppressed fibronectin, collagen-1, and α-SMA, and preserved E-cadherin, while inhibiting Smad3 activation and nuclear translocation of Smad2/3/4.
Conclusions:
- CTS ameliorates kidney fibrosis and EMT.
- CTS acts, at least partly, by inhibiting the TGF-β1/Smad3/integrin β1 signaling pathway.
- CTS demonstrates potential as a therapeutic agent for kidney fibrosis.
Related Concept Videos
TGF - β Signaling Pathway
Forced Transdifferentiation
Artificial...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Feedback Inhibition
Endocrine Signaling

